Ms. Ivana Maric reports

AVICANNA TRANSITIONS US LISTING TO OTCQB

In the United States, Avicanna Inc. will transition to OTCQB effective Oct. 16, 2026.

About Avicanna Inc.

Avicanna is an international biopharmaceutical company specializing in the commercialization of proprietary and evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has established scientific and medical affairs platforms that support its four commercial-stage business pillars and have resulted in the commercialization of more than 50 finished products.

We seek Safe Harbor.